AllSight
Companies · ENTX · Biological Products, (No Diagnostic Substances)

Entera Bio Ltd. (ENTX)

Entera Bio Ltd. (ENTX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Aug 7, 2026
Phase 3 funding and FDA alignment confirmed, but quarterly loss missed expectations
Related companies in Biological Products, (No Diagnostic Substances)
RXRXBCRXKYMRRVMDEXELPCVXTWSTIMCRGLUEIOVATARSRGNX
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact